Central nervous system lymphoma

Lymphoma: Pathology, Diagnosis and Treatment

Volumn , Issue , 2007, Pages 200-214

  Ferreri, Andres J M ^a   DeAngelis, Lisa M ^b  

^a SAN RAFFAELE HOSPITAL   (Italy)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 53249126225     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1017/CBO9780511663369.015     Document Type: Chapter

References (10)

1. Abrey, L. E., Batchelor, T. T., Ferreri, A. J. et al. Report of an international workshop to standardize baseline evaluation and response criteria for primary CNS lymphoma. J. Clin. Oncol. 23(2005), 5034–5043.
2. DeAngelis, L. M. and Hormigo, A. Treatment of primary central nervous system lymphoma. Semin. Oncol. 31 (2004),684–692.
3. DeAngelis, L. M., Seiferheld, W., Schold, S. C. et al. Combination chemotherapy and radiotherapy for primary central nervous system lymphoma: Radiation Therapy Oncology Group Study 93–10. J. Clin. Oncol. 20 (2002), 4643–4648.
4. Ferreri, A. J., Abrey, L. E., Blay, J. Y. et al. Summary statement on primary central nervous system lymphomas from the Eighth International Conference on Malignant Lymphoma, Lugano,Switzerland, June 12 to 15, 2002. J. Clin. Oncol. 21 (2003),2407–2414.
5. Ferreri, A. J., Reni, M., Pasini, F. et al. A multicenter study of treatment of primary CNS lymphoma. Neurology 58 (2002),1513–1520.
6. Hoffmann, C., Tabrizian, S., Wolf, E. et al. Survival of AIDS patients with primary central nervous system lymphoma is dramatically improved by HAART-induced immune recovery. AIDS 15 (2001), 2119–2127.
7. Hollender, A., Kvaloy, S., Nome, O. et al. Central nervous system involvement following diagnosis of non-Hodgkin'slymphoma: a risk model. Ann. Oncol. 13 (2002), 1099–1107.
8. Kasamon, Y. L. and Ambinder, R. F. AIDS-related primary central nervous system lymphoma. Hematol. Oncol. Clin.North Am. 19 (2005), 665–687.
9. van Besien, K., Forman, A. and Champlin, R. Central nervous system relapse of lymphoid malignancies in adults: the role of high-dose chemotherapy. Ann. Oncol. 8 (1997), 515–524.
10. van Besien, K., Ha, C. S., Murphy, S. et al. Risk factors, treatment, and outcome of central nervous system recurrence in adults with intermediate-grade and immunoblastic lymphoma. Blood 91 (1998), 1178–1184.